Author:
Horikoshi Akira,Takei Kazuhiro,Hosokawa Yoshifumi,Sawada Shigemasa
Publisher
Springer Science and Business Media LLC
Reference33 articles.
1. Champlin R, Gale RP. Acute myelogenous leukemia: recent advances in therapy. Blood. 1987;69:1551–62.
2. Estey EH. Treatment of relapsed and refractory acute myelogenous leukemia. Leukemia. 2000;14:476–9.
3. Liu Yin JA. Acute myeloid leukaemia in the elderly: biology and treatment. Br J Haematol. 1993;83:1–6.
4. Mayer RJ, Davis RB, Schiffer CA et al. Intensive postremission chemotherapy in adults with acute myeloid leukemia. N Engl J Med. 1994;331:896–903.
5. Löwenberg B, Suciu S, Archimbaud E et al. Use of recombinant granulocyte-macrophage colony-stimulating factor during and after remission induction chemotherapy in patients aged 61 years and older with acute myeloid leukemia (AML): final report of AML-11, a phase III randomized study of the Leukemia Cooperative Group of European Organization for the Research and Treatment of Cancer (EORTC-LCG) and the Dutch Belgian Hemato-Oncology Cooperative Group (HOVON). Blood. 1997;90:2952–61.
Cited by
10 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献